Download Call for Abstracts (2,63 MB)
Submissions of the following scientific contributions are welcome:
Deadline
Abstracts must be submitted by 8 pm (CET), December 1st, 2009.
Guidelines Abstract Submission
A special criterion for accepting abstracts will be their structure, content and degree of innovation.
Content and Form
The abstracts will be reviewed anonymously by the WOC®2010 submitted program reviewing committee. In order to make their work as efficient and the selection as objective as possible, the following guidelines should be followed.
Procedure for the submission of abstracts
The submission of abstracts will be processed via a system that works web-based. The submission of abstracts can be made via the homepage www.woc2010.org. The transmission of abstracts in English has to be made via document-upload.
Please accomplish the following proceedings:
Corrections within the text can only be done by uploading a new document.
Confirmation
By submitting the abstract via Internet (www.woc2010.org), the author confirms that all co-authors have agreed to the submission of the abstract and that the authors take full responsibility for the contents. The authors thereby guarantee that the submitted abstract describes own results and that clinical studies have been proceeded with approval of the ethics committee and animal tests have been proceeded with the official permission from the proper authorities.
Video Presentation
Please send your video including your abstracts by 16 December 2009 to:
WOC 2010
c/o Porstmann Kongresse GmbH
Alte Jakobstr. 77
10179 Berlin
Germany
Videos will only be accepted if submitted as DV tape, mini DV tape or DVD according to PAL. All videos shall include sound and shall not exceed 10 minutes.
Publication
Abstracts should be submitted in clear and concise English. The abstracts will be published.
Structure of the Abstract
The structure of the abstract should be as follows:
a. Background and Purpose
b. Methods
c. Results
d. Conclusions
Do not include any figures and tables.
The text should be structured as follows:
– Type the abstract using single-space and 11 font size arial letters.
– The text should not exceed 13 cm width and 17 cm length.
– Please note that a maximum of 2500 characters including blanks is permitted. The titles and the names of the authors are excluded from this number and have to be entered separately.
Each author is allowed to submit only 1 abstract of an oral presentation and 1 abstract of a poster as first author. Statements like "Results will be discussed" are not acceptable and may lead to a rejection of the abstract.
Classification codes
1 | Anatomy/pathology |
2 | Biochemistry/pharmacology |
3 | Ethics/medical history/traffic ophthalmology |
4 | Genetics |
5 | Glaucoma |
5.1 | Basics |
5.2 | Diagnostics |
5.3 | Medical therapy |
5.4 | Surgical therapy |
5.5 | Miscellaneous |
6 | Uveitis/intraocular inflammation, microbiology/immunology |
7 | New technology, Bioengineering, Nanotechnology |
8 | International ophthalmology |
9 | Cataract/biometry |
10 | Epidemiological studies |
11 | Cornea/Eye Bank |
11.1 | Basics |
11.2 | Diagnostics |
11.3 | Medical therapy |
11.4 | Surgical therapy |
11.5 | Miscellaneous |
12 | Conjunctiva/contact lenses |
13 | Epidemiology |
14 | External Disease |
15 | Low Vision |
16 | Neuro-Ophthalmology |
17 | Oncology |
18 | Physiological optics/psychophysics/electrophysiology |
19 | Oculoplasty/orbita/lids/lacrimal system |
20 | Pediatric Ophthalmology & Genetics |
21 | Refractive surgery/Refraction |
22 | Retina/chorioidea/RPE/vitreous |
22.1 | Basics |
22.2 | Diagnostics |
22.3 | Medical therapy |
22.4 | Surgical therapy |
22.5 | Trauma/Emergencies |
22.6 | AMD |
22.7 | Vascular diseases |
22.8 | RPE diseases |
22.9 | Miscellaneous |
23 | Strabismus |
24 | Teleophthalmology |
25 | Trauma |
26 | Vision 2020 - Prevention of Blindness |
27 | Miscellaneous |
Financial disclosure
The disclosure of commercial relationships is expected. Bias in research, presentation and publication can arise from various forms of self-interest. The desire for professional recognition is inherent in academic activity, often with the indirect fringe benefits of increased stature and authority, academic appointment or promotion, more patient referrals, higher income, more travel, or other perquisites. These potential rewards for academic success can be a strong sources of bias. More tangible financial benefits can also accrue to the First Author or Co-author in some cases. Financial interests do not restrict presentation or publication, but the audience is entitled to know that such interests exist. Therefore, presenters at the WOC2010 meeting (including poster sessions) and other educational activities are required to provide disclosure of financial interests.
Category | Abbreviation | Description of the financial Interests |
Product | P | Financial interest in equipment, process or product presented. |
| P c | Similar interest in a potential competitor. |
Investor | I | Financial interest in a company or companies supplying equipment, process or product presented. |
| I c | Similar dependence on a potential competitor. |
Employee | E | Employee of an involved company. |
| E c | Employee of a competitor of an involved company. |
Consultant* | B | Commercial payment or support during the last three years in form of the research funds or material in equipment, process or products presented. |
| B c | Similar payment or support from a potential competitor. |
None | K | No financial interest and no commercial support in the case of the work presented. |
| ||
B 1 or B c 1 | A recipient of regular benefits (Retainer) (e.g. salaried earner) | |
B 2 or B c 2 | Contract payment for research performed | |
B 3 or B c 3 | Ad hoc consultation fees | |
B 4 or B c 4 | Substantial non-monetary benefits | |
B 5 or B c 5 | Contribution to research or research funds | |
B 6 or B c 6 | Beiträge zu Reisekosten | |
B 7 or B c 7 | Reimbursement of travel expenses for presentations at meetings or courses | |
B 8 or B c 8 | Reimbursement of travel expenses for direct consultation | |
Examples for economic and financial linkage:
For all these categories an appropriate code as described above is required. Please note the category on the abstract form.
Publication of Scientific Papers of DOG members
Scientific contributions that have been accepted for oral presentation have to be handed in in publishable format for peer reviewing no later than 31 October 2010. Publication is possible in either German or English.
Please send your manuscript to the respective editors:
German language contributions for review by the journal "Der Ophthalmologe" should be submitted online only. Full details concerning submission are available at: www.DerOphthalmologe.de or directly at: www.editorialmanager.com/deop/
Editor-in-Chief
Prof. Dr. med. Frank G. Holz
Universitäts-Augenklinik Bonn
Ernst-Abbe-Str. 2
53127 Bonn
German-language contributions for review by the journal "Klinische Monatsblätter für Augenheilkunde" should be sent online to:
http://mc.manuscriptcentral.com/klimo
Editors-in-Chief
Prof. Dr. med. Gerhard K. Lang, Prof. Dr. med. Gabriele E. Lang
Universitäts-Augenklinik Ulm
Prittwitzstr. 43
89075 Ulm
English-language contributions for review by the journal "Graefe's Archive for Clinical and Experimental Ophthalmology" should be submitted online only. Full details concerning submission are available at:
www.medizin.uni-koeln.de/kliniken/augenklinik/graefe.html or directly at:
http://mc.manuscriptcentral.com/graefes
Editor-in-Chief
Prof. Dr. med. Bernd Kirchhof
Klinikum der Universität zu Köln
Zentrum für Augenheilkunde
Kerpener Str. 62
50924 Köln
Copyright for oral presentations to be made at the congress by DOG members belong to the society. That is why authors of oral presentations are obliged to submit their contributions for review and publication by one of the following journals: "Der Ophthalmologe", "Klinische Monatsblätter für Augenheilkunde" or "Graefe's Archive for Clinical and Experimental Ophthalmology". Upon request, the presentation may also be published in another journal. In this case the author is asked to send an informal application to the Secretary of the DOG. Contributions published in other journals shall annotate: "presented at the 108th DOG Congress".
All authors are kindly asked to observe the "Instructions for Authors" of the respective journals. Manuscripts not accepted for publication after the review process will be returned to the respective author with the reviewers' evaluation.